510(k) K983841
K983841 is an FDA 510(k) premarket notification submitted by Biotest Diagnostics Corp. for the device "BIOTEST ANTI-EBV RECOMBINANT, EBNA IGG". The FDA issued a decision of Substantially Equivalent on Jun 9, 1999. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Biotest Diagnostics Corp. has 4 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 9, 1999
- Date Received
- Oct 30, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Epstein-Barr Virus, Other
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Biotest Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.